36.29
price up icon2.51%   0.89
pre-market  Pre-mercato:  36.65   0.36   +0.99%
loading
Precedente Chiudi:
$35.40
Aprire:
$35.27
Volume 24 ore:
1.38M
Relative Volume:
0.55
Capitalizzazione di mercato:
$6.26B
Reddito:
$264.79M
Utile/perdita netta:
$-14.36M
Rapporto P/E:
-329.91
EPS:
-0.11
Flusso di cassa netto:
$-28.11M
1 W Prestazione:
-2.60%
1M Prestazione:
+1.51%
6M Prestazione:
+16.84%
1 anno Prestazione:
+98.20%
Intervallo 1D:
Value
$35.03
$36.35
Intervallo di 1 settimana:
Value
$35.03
$38.08
Portata 52W:
Value
$16.65
$46.48

Tg Therapeutics Inc Stock (TGTX) Company Profile

Name
Nome
Tg Therapeutics Inc
Name
Telefono
(212) 554-4484
Name
Indirizzo
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY
Name
Dipendente
352
Name
Cinguettio
@TGTherapeutics
Name
Prossima data di guadagno
2025-03-03
Name
Ultimi documenti SEC
Name
TGTX's Discussions on Twitter

Confronta TGTX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
TGTX
Tg Therapeutics Inc
36.29 6.26B 264.79M -14.36M -28.11M -0.11
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Tg Therapeutics Inc Stock (TGTX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-10-29 Iniziato TD Cowen Buy
2023-08-02 Aggiornamento Goldman Sell → Neutral
2023-06-26 Ripresa Jefferies Buy
2022-05-20 Iniziato BofA Securities Underperform
2022-02-23 Reiterato B. Riley Securities Buy
2021-11-15 Downgrade Goldman Neutral → Sell
2021-04-20 Iniziato Goldman Neutral
2021-04-19 Reiterato H.C. Wainwright Buy
2020-09-01 Iniziato JP Morgan Overweight
2020-08-11 Reiterato H.C. Wainwright Buy
2020-06-05 Iniziato Evercore ISI Outperform
2020-01-17 Reiterato H.C. Wainwright Buy
2019-11-27 Ripresa B. Riley FBR Buy
2019-02-06 Ripresa Jefferies Buy
2018-09-25 Downgrade Raymond James Strong Buy → Outperform
2018-03-09 Reiterato B. Riley FBR, Inc. Buy
2017-12-01 Ripresa B. Riley FBR, Inc. Buy
2017-11-14 Ripresa H.C. Wainwright Buy
2017-04-25 Iniziato Jefferies Buy
2017-03-06 Reiterato FBR & Co. Outperform
2016-10-06 Ripresa Brean Capital Buy
2016-05-27 Iniziato SunTrust Buy
2015-12-01 Iniziato FBR Capital Outperform
2015-09-09 Iniziato Raymond James Strong Buy
2015-08-12 Ripresa H.C. Wainwright Buy
2015-06-19 Reiterato Brean Capital Buy
2014-12-11 Reiterato ROTH Capital Buy
2014-12-10 Reiterato ROTH Capital Buy
Mostra tutto

Tg Therapeutics Inc Borsa (TGTX) Ultime notizie

pulisher
Jun 17, 2025

Insider Selling: Yann Echelard Unloads $369K Of TG Therapeutics Stock - Nasdaq

Jun 17, 2025
pulisher
Jun 17, 2025

Tg therapeutics director Yann Echelard sells $369,400 in stock - Investing.com Australia

Jun 17, 2025
pulisher
Jun 17, 2025

(TGTX) Trading Advice - news.stocktradersdaily.com

Jun 17, 2025
pulisher
Jun 17, 2025

Tg therapeutics director Yann Echelard sells $369,400 in stock By Investing.com - Investing.com Canada

Jun 17, 2025
pulisher
Jun 16, 2025

TGTX Experiences Surge in Bullish Options Activity | TGTX Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Are Options Traders Betting on a Big Move in TG Therapeutics Stock? - Yahoo Finance

Jun 16, 2025
pulisher
Jun 13, 2025

TG Therapeutics shareholders approve key proposals By Investing.com - Investing.com South Africa

Jun 13, 2025
pulisher
Jun 13, 2025

TG Therapeutics Approves Key Proposals at Annual Meeting - TipRanks

Jun 13, 2025
pulisher
Jun 13, 2025

TG Therapeutics shareholders approve key proposals - Investing.com

Jun 13, 2025
pulisher
Jun 10, 2025

TG Therapeutics at Goldman Sachs Conference: Strategic Growth and Innovations - Investing.com Canada

Jun 10, 2025
pulisher
Jun 10, 2025

Transcript : TG Therapeutics, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 10 - marketscreener.com

Jun 10, 2025
pulisher
Jun 09, 2025

GAMMA Investing LLC Purchases 176,573 Shares of TG Therapeutics, Inc. (NASDAQ:TGTX) - Defense World

Jun 09, 2025
pulisher
Jun 06, 2025

TG Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference - GlobeNewswire

Jun 06, 2025
pulisher
Jun 06, 2025

TG Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference | TGTX Stock News - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

TG Therapeutics (NasdaqCM:TGTX) Stock Rises 13% In Last Month - Yahoo

Jun 06, 2025
pulisher
Jun 06, 2025

Kalkine: TG Therapeutics Schedules Fireside Chat at Goldman Sachs Conference Amid FT100 Futures Focus - Kalkine Media

Jun 06, 2025
pulisher
Jun 06, 2025

TG Therapeutics CEO Fireside Chat at Goldman's Premier Healthcare Conference: Key Updates Coming - Stock Titan

Jun 06, 2025
pulisher
Jun 06, 2025

Two Sigma Advisers LP Sells 214,800 Shares of TG Therapeutics, Inc. (NASDAQ:TGTX) - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

LAWSUITS FILED AGAINST U, TGTX and CVNAJakubowitz Law Pursues Shareholders Claims - ACCESS Newswire

Jun 05, 2025
pulisher
Jun 05, 2025

Transcript : TG Therapeutics, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 12 - marketscreener.com

Jun 05, 2025
pulisher
Jun 04, 2025

(TGTX) Investment Analysis and Advice - news.stocktradersdaily.com

Jun 04, 2025
pulisher
Jun 03, 2025

TG Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - The Globe and Mail

Jun 03, 2025
pulisher
Jun 02, 2025

TG Therapeutics to Participate in the Jefferies Global Healthcare Conference - The Manila Times

Jun 02, 2025
pulisher
Jun 02, 2025

TG Therapeutics CEO Fireside Chat: Key Updates Expected at Major Healthcare Conference - Stock Titan

Jun 02, 2025
pulisher
May 31, 2025

TG Therapeutics shares MS drug trial updates By Investing.com - Investing.com South Africa

May 31, 2025
pulisher
May 30, 2025

TG Therapeutics Announces Data Presentations for BRIUMVI in Mult - GuruFocus

May 30, 2025
pulisher
May 30, 2025

TG Therapeutics shares MS drug trial updates - Investing.com

May 30, 2025
pulisher
May 30, 2025

TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting | TGTX Stock News - GuruFocus

May 30, 2025
pulisher
May 30, 2025

TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting - The Manila Times

May 30, 2025
pulisher
May 30, 2025

TG Therapeutics Highlights BRIUMVI® Data in Patients with Relapsing Forms of Multiple Sclerosis at CMSC 2025 Annual Meeting - Nasdaq

May 30, 2025
pulisher
May 30, 2025

TG Therapeutics Announces Data Presentations for BRIUMVI in - GlobeNewswire

May 30, 2025
pulisher
May 28, 2025

TG Therapeutics: Estimates Could Soon Be Raised Again (NASDAQ:TGTX) - Seeking Alpha

May 28, 2025
pulisher
May 28, 2025

Man Group plc Purchases Shares of 9,589 TG Therapeutics, Inc. (NASDAQ:TGTX) - Defense World

May 28, 2025
pulisher
May 27, 2025

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting | TGTX Stock News - GuruFocus

May 27, 2025
pulisher
May 27, 2025

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting - The Manila Times

May 27, 2025
pulisher
May 27, 2025

TG Therapeutics Announces Schedule of Data Presentations - GlobeNewswire

May 27, 2025
pulisher
May 27, 2025

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® in Multiple Sclerosis at ... - Eagle-Tribune

May 27, 2025
pulisher
May 27, 2025

Bank of America Corp DE Has $6.95 Million Stake in TG Therapeutics, Inc. (NASDAQ:TGTX) - Defense World

May 27, 2025
pulisher
May 27, 2025

TG Therapeutics Announces Schedule of Data Presentations for BRI - GuruFocus

May 27, 2025
pulisher
May 25, 2025

How To Trade (TGTX) - news.stocktradersdaily.com

May 25, 2025
pulisher
May 22, 2025

Captrust Financial Advisors Sells 22,765 Shares of TG Therapeutics, Inc. (NASDAQ:TGTX) - Defense World

May 22, 2025
pulisher
May 21, 2025

Exploring 3 High Growth Tech Stocks In The US Market - Yahoo Finance

May 21, 2025
pulisher
May 19, 2025

TG Therapeutics, Inc. (NASDAQ:TGTX) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World

May 19, 2025
pulisher
May 18, 2025

TG Therapeutics, Inc. (NASDAQ:TGTX) Shares Sold by BNP Paribas Financial Markets - Defense World

May 18, 2025
pulisher
May 16, 2025

TG Therapeutics' (NASDAQ:TGTX) Weak Earnings May Only Reveal A Part Of The Whole Picture - simplywall.st

May 16, 2025
pulisher
May 16, 2025

Investor Calendar Invites You to the TG Therapeutics, Inc. Third Quarter 2016 Earnings Conference Call and Webcast Live on Monday, November 7, 2016 - ACCESS Newswire

May 16, 2025
pulisher
May 15, 2025

(TGTX) Long Term Investment Analysis - news.stocktradersdaily.com

May 15, 2025
pulisher
May 13, 2025

TG Therapeutics Boosts Retail Sentiment With Q1 Revenue Beat Even As Stock Tumbles On Profit Miss, Conservative Outlook - MSN

May 13, 2025

Tg Therapeutics Inc Azioni (TGTX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Capitalizzazione:     |  Volume (24 ore):